Top 25 Medical Device Angel Investors in Canada in December 2024
A list of 25 angel investors that invest in Medical device startups based in Canada. We rank investors based on the number of investments they made in Medical device companies from Canada. We update this investor list every month.Top 25 Medical Device Angel Investors in Canada in December 2024
Investor | Medical Device Canada investments |
---|---|
Ray Muzyka | 3 |
James Lochrie | 2 |
Paul Geyer | 2 |
Noel Hall | 2 |
Ryan Pawell | 1 |
Ross Finlay | 1 |
Andres Pinter | 1 |
Barney Pell | 1 |
Yoshua Bengio | 1 |
Paul Buchheit | 1 |
Marc G. Bellemare | 1 |
Sandra MacPherson | 1 |
Manjit Minhas | 1 |
Haig Farris | 1 |
Carlo Perez | 1 |
Jacky Chen | 1 |
Dr. Andrew Vellathottam | 1 |
Huda Idrees | 1 |
Milad Alucozai | 1 |
Hugo Larochelle | 1 |
T. Chen Fong | 1 |
Edwin Liang | 1 |
Justin Allport | 1 |
Wei Guo | 1 |
Dr. Gaurav Puri | 1 |
Originally trained as a medical doctor, Dr. Ray Muzyka cofounded BioWare, a video game development studio focusing on story and character, in the early 1990s. He practiced emergency/family medicine for two years full time, with medicine transitioning to part-time over the following decade as he focused on his role as BioWare’s CEO. BioWare wasacquired by Electronic Arts in 2007, and Dr. Muzyka took on the roles of Senior Vice President at Electronic Arts and General Manager of EA’s BioWare division, which grew over the next five years to span eight development locations worldwide with about 2000 staff (1400 full time). He retired from video games in October 2012, with his third “career chapter” at ThresholdImpact, where he focused on sustainable, profitable impact investing: mentoring and angel investing in information technology, new media, and medical innovations with social entrepreneurs. An active angel investor and entrepreneurial mentor, Dr. Muzyka is a member of the Young Presidents’ Organization, the A100, the Ashoka Support Network, and the Board of Governors of the University of Alberta (serving as Chair of the Human Resources Committee and on the Learning and Discovery Committee and as a member of the University of Alberta Advancement Council). He is Chair of the University of Alberta’s entrepreneur Venture Mentoring Service, a venture advisor at iNovia Venture Capital, and a member of the Alberta Research and Innovation Advisory Committee and the Alberta Premier’s Advisory Committee on the Economy. He also serves on a number of private company boards. He previously served on the board of the Academy of Interactive Arts and Sciences from 2001-2008 and was on the Board of Trustees of the Stollery Children’s Health Foundation from 2012-2015. He was inducted into the Academy of Interactive Arts and Sciences’ Hall of Fame in 2011 and received the International Game Developers’ Choice Awards 2013 Lifetime Achievement Award. Dr. Muzyka received the inaugural Alumni Innovation Award in 2015 from the University of Alberta. He additionally was named as the 2017 Allard Chair in Business at the MacEwan University’s School of Business and as an Honorary Paul Harris Fellow by Rotary Club International in 2016, in recognition for his philanthropic efforts. Other awards include entry into Canada’s Top 40 under 40 and Ernst and Young’s 2001 Entrepreneur of the Year (IT, Prairies).He obtained his Bachelor of Medical Science from the University of Alberta in 1990, his Doctorate of Medicine from there in 1992, and his MBA from the University of Western Ontario (Ivey School of Business) in 2001.
Show more
Investment focus
- Health Care, Software, Information Technology
- Seed, Pre-Seed, Funding Round
- Canada, United States
Portfolio highlights
- Leadoptik — Leadoptik is a California-based company is currently operating in stealth mode.
- Modality.AI, Inc. — Modality.ai is an AI-powered platform that detects health conditions using conversational AI. Through dialogue and video, Modality.AI interacts conversationally with the patient to provide health assessment anywhere, anytime. Its system analyzes multimodal data which allows continuous screening and assessing of patients’ health.
- Gray Oncology Solutions — Gray Oncology Solution is a healthcare enterprise software company that commercializes GrayOS, the operating system for oncology.
James Lochrie is an entrepreneur, angel investor, venture capitalist and volunteer. He is the Co-founder of the global fintech company Wave. He is a Partner at Thin Air Labs, overseeing Thin Air Fund 1 and the Capital team. He has worked with thousands of entrepreneurs to help them scale their companies and #BuildWhatsNext.
Show more
Investment focus
- Software, Analytics, Health Care
- Seed, Angel, Pre-Seed
- Canada
Portfolio highlights
- SomaDetect — SomaDetect measures every critical indicator of dairy quality (fat, protein, somatic cell counts, progesterone) from every cow at every milking. It uses no consumables (no chemicals, no cartridges, no lost milk), is extremely quick (results in seconds, not minutes), and accurate.
- PayShepherd — PayShepherd helps manage contractor billing for industrial facilities and simplifies billing processes. Save time, money, and headaches.
- StellarAlgo — Drive fan engagement and revenue across the entire fan journey. For Major Leagues, Emerging Leagues, Live Events, Media & Gaming, and Corporate Partnerships.
Paul Geyer, a successful Medtech Entrepreneur and experienced Board member. Over the past 20 years Paul founded and led two companies through their growth phase, in one case to a successful private exit and in the other case through growth as a public company with numerous acquisitions. Both companies have grown to be anchor medical devicecompanies in the Vancouver area, employing more than 350 people.In 1991 he founded Mitroflow International Inc., a tissue heart valve company. Paul grew the company from 9 employees to more than 125 employees in 1999. In 1999 Paul sold Mitroflow to Sulzer Medica, for more than $50 mil. Paul's leadership resulted in Mitroflow growing to more than 200 employees, making it one of the largest medical devices companies in the Vancouver area. In 2001 Paul started Medical Ventures, a new specialty vascular device company where he is currently Chairman of the Board. From its inception to June 2008, Geyer held the position of CEO at Medical Ventures (now Neovasc) and was responsible for raising over $40 million in Equity financing and growing the company’s product portfolio through internal development and the acquisition of 3 other companies. In 2008 Paul began focusing on sharing is expertise to assist other Entrepreneurs to build successful businesses, through his involvement as a mentor or Board member. He also focused on building the local community through his involvement as a Board member of BC technology industry association, along with a number of non-profit community based organizations. Paul is actively engaged as a Philanthropist, as Chairman of the Board of Social Venture Partners Vancouver, involved with Science World, Entrepreneurship at UBC, Project Somos Children’s Village and other organizations.Paul is currently the CEO of LightIntegra Technology Inc., a spin-off from Canadian Blood Services which has developed the ThromboLux technology, used to determine platelet quality for blood transfusions.
Show more
Investment focus
- Health Care, Fitness, Medical Device
- Seed, Series A, Funding Round
- Canada, United States
Portfolio highlights
- Stoko design — Get the same level of joint support as a rigid knee brace in the form of a compression tight. Covered by insurance. Fast & free shipping. Hassle-free returns. Backed by orthopedic surgeons. Recommended by Olympians.
- Arbutus Medical — Arbutus Medical manufactures medical devices that simplifies orthopedic surgery and reduce the cost of healthcare to help treat patients worldwide.
- HeadCheck Health — HEADCHECK HEALTH simplifies the process of executing and monitoring concussion protocols. Learn more!
Noel Hall is the Director of Corporate of Wellcome Trust. He is a former Board Director, Co-founder, and President of Aspreva Pharmaceuticals Corp. He attended the University of London.
Show more
Investment focus
- Biotechnology, Genetics, Life Science
- Seed, Angel
- Canada, United States
Portfolio highlights
- Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
- Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.
Ryan Pawell (Founder, Director & Chief Executive Officer) is a Y Combinator alumni, published author and subject matter expert in the areas of fluid dynamics, advanced manufacturing, and biomicrofluidics. Ryan has been invited to present his work by the Australian National Fabrication Facility, White House Cancer Moonshot Taskforce, Air Force,National Institutes of Health, and National Cancer Institute among others.
Show more
Investment focus
- Medical, Biopharma, Biotechnology
- Seed
- Canada, United States
Portfolio highlights
- Pioneer Fund — 300+ YC alumni investing in the top YC startups
- Avro — Avro Life Science is developing skin patches for generic drug delivery, focusing on therapeutics for children and the elderly. The core of our technology is a novel biopolymer which is used as a platform for passive transdermal drug delivery of small molecules and drugs.
Ross Finlay, a Co-founder and Director of the First Angel Network Association has been an angel investor since 2000. He has assisted many companies in raising private equity. Mr. Finlay is a recognized facilitator, senior business consulting professional and strategic change consultant who has an extensive background in public, private andnot-for-profit sectors. He has implemented major business changes in a number of organizations and has experience in conducting organizational reviews in the public/private and the not-for-profit sectors. He has extensive business networks throughout Atlantic Canada. He has been Executive Director of a provincial professional association and President of a national consulting company working with scientific, engineering and technical areas. Since his move home to Nova Scotia, Ross has managed his own successful consulting practice. He returned to the corporate world for a time with PricewaterhouseCoopers LLP and SolutionInc Ltd. – a Halifax based software development company. In 2002 Ross was a recipient of the Queen Elizabeth II Jubilee Medal for outstanding community service through his efforts in numerous charities.
Show more
Investment focus
- Energy, Aerospace, CleanTech
- Seed
- Canada
Portfolio highlights
- Meta Materials — META® delivers previously unachievable performance, across a range of applications, by inventing, designing, developing, and manufacturing sustainable, highly functional materials. Our extensive technology platform enables leading global brands to deliver breakthrough products to their customers in consumer electronics, 5G communications, healthand wellness, aerospace, automotive, and clean energy. Our nano-optic technology provides anti-counterfeiting security features for government documents and currencies and authentication for brands. Our achievements have been widely recognized, including being named a Lux Research Innovator of the Year in 2021. Learn more at www.metamaterial.com.
Andres Pinter is a Techstars Mentor and angel investor based in Los Angeles, CA.
Show more
Investment focus
- Electronics, Health Care, Medical Device
- Funding Round
- Canada
Portfolio highlights
- GestSure — GestSure was created to solve the problem of in-OR sterile information access. Using cutting-edge machine vision technology, GestSure empowers surgeons to achieve better patient care while saving time and resources.Their system provides a touchless interface that enables surgeons to navigate their patient information using simple hand gestures.From within the sterile field, the surgeon can use a simple set of gestural commands to control their existing software. The simple plug-and-play system is compatible with all medical imaging viewers and requires minimal hospital IT support.
Barney Pell was the co-founder, Chairman and Chief Strategy Officer of LocoMobi Inc. Barney has a long history as a leading technology innovator, product visionary, entrepreneur and angel investor based in Silicon Valley. Barney is known for being an Entrepreneur-in-Residence at Mayfield, a top Venture Capital firm, which he left to becomeFounder and CEO of Powerset, which built a natural-language based search engine that read each sentence in Wikipedia and answered user queries in plain English. Microsoft acquired Powerset in 2008 to help create its new search engine, Bing. Barney then served Microsoft as Search Strategist, Evangelist, and Chief Architect for Local Search at Bing, until leaving Microsoft in September 2011 to return to the start-up world full-time.Barney also has active investor, board member, and advisory roles with multiple start-up companies and non-profits across a variety of industries. Barney is Co-Founder, Vice Chairman and Chief Technology Officer of Moon Express, a private company building autonomous robotic lunar landers to enable exploration and commercial development of the solar system. This builds on his earlier career managing advanced software technologies at NASA. Highlights of innovations during Barney’s career at NASA include mission critical software to support planning and collaboration for the Mars Exploration Rovers mission; Clarissa, the first spoken dialog system in space; and the development of the Remote Agent, the first AI system to fly onboard and control a deep space probe. Remote Agent is widely considered one of the top achievements in the history of Artificial Intelligence and was awarded NASA’s "software of the year" award in 1999. Barney is also Associate Founder and Trustee of Singularity University (SU), a new university created to educate leaders for life in a future driven by accelerating technological change.Other recent active angel investments and advisory positions include: Getaround, Robotex, Halcyon Molecular, SpaceX, and CrowdFlower. Recent start-ups that have had successful exits include: Appjet (now Google), Aardvark (now Google), Hot Potato (now Facebook), Etacts (now SalesForce.com), Movity (now Trulia), and LinkedIn, the world’s largest professional social network which recently went public after acquiring its hundred-millionth member.Barney received his Ph.D. in Computer Science from Cambridge University, where he was a Marshall Scholar, and his B.S. degree in Symbolic Systems from Stanford University, where he graduated Phi Beta Kappa and was a National Merit Scholar.Barney is a frequent speaker at conferences and universities. These include keynote talks at the International Joint Conference on Artificial Intelligence, the Association for Computational Linguistics, Search Marketing Expos, International Semantic Web Conference, World Wide Web Conference, the Informational Retrieval Conference, and panels at SXSW Interactive. Barney has also spoken at the NPA and IPI conferences and has been featured in all major Parking industry magazines.
Show more
Investment focus
- Information Technology, Mobile, Software
- Seed, Series A, Pre-Seed
- United States, Canada
Portfolio highlights
- Workwolf — Workwolf is a Toronto-based start-up with a management team who has led 7 start-ups, had 2 successful exits, and has taken a company public with a $1.8B IPO. Workwolf CEO Erik Simins is an SME in HR who previously founded MAGNUS HRS, a staffing company now servicing over 150 enterprise customers. The technology at Workwolf solves two of the biggestpain points in employment: applicant filtration and verification, and does so by empowering users to identify better candidates faster. Winner of global awards in both 2020 and 2021 for innovation and market potential, Workwolf is ramping up for its multi-national roll-out with ManpowerGroup in September that will coincide with a $4.5M Seed financing round.
- Ada — Ada is a computer software company that features a chatbot-based platform that helps enterprise businesses to automate customer experience. Its platform operates through both web and mobile machine learning engine that reduces support volume and empowers customers to find answers on their own.The company was founded in 2016 and headquartered inToronto in Canada.
- A&K Robotics — A&K Robotics | Autonomous Vehicle Systems
Yoshua Bengio (PhD in CS, McGill University, 1991), post-docs at M.I.T. (Michael Jordan) and AT&T Bell Labs (Yann LeCun), CS professor at Université de Montréal, Canada Research Chair in Statistical Learning Algorithms, NSERC Chair, CIFAR Fellow, member of NIPS foundation board and former program/general chair, co-created ICLR conference,authored two books and over 300 publications, the most cited being in the areas of deep learning, recurrent networks, probabilistic learning,natural language and manifold learning. He is among the most cited Canadian computer scientists and is or has been associate editor of the top journals in machine learning and neural networks.
Show more
Investment focus
- Artificial Intelligence, Software, Health Care
- Seed, Pre-Seed, Series A
- Canada, France, United States
Portfolio highlights
- Entalpic — Entalpic is an AI-driven discovery platform for sustainable industries aiming to optimize carbon-intensive sectors.
- Reliant AI — Reliant AI operates as an AI generated data analytics software provider.
- Abridge — For patients, clinicians, and enterprise, our audio-based solutions capture the details and summarize medical conversations, anywhere care happens.
Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.
Show more
Investment focus
- Software, Health Care, E-Commerce
- Seed, Series A, Angel
- United States, Canada, India
Portfolio highlights
- SiPhox Health — SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
- Character.ai — Chat with millions of AI Characters anytime, anywhere. Super-intelligent chat bots that hear you, understand you, and remember you. Free to use with no ads.
- Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Marc G. Bellemare is a Research Scientist at Deepmind.
Show more
Investment focus
- Software, Health Care, Medical Device
- Pre-Seed
- Canada
Portfolio highlights
- Ubenwa Health — Ubenwa is a medtech company using AI to analyze infant cries, turning devices with microphones into life-saving tools for early health detection. Discover our cutting-edge technology today.
Sandra MacPherson
Show more
Investment focus
- Genetics, Biotechnology, Medical Device
- Seed
- Canada
Portfolio highlights
- Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.
34-year-old Manjit Minhas is the co-founder and co-owner of Minhas Breweries and Distillery and a Dragon on Dragon's Den. Though trained as a petroleum engineer, she has become a specialist in brand development, marketing, sales management and retail negotiations, having been recognized for several business industry awards such as PROFITmagazine's "Top Growth Entrepreneur", Top 100 Women Entrepreneurs in Canada, Calgary's Top 40 under 40, Chatelaine Magazine's "Top Entrepreneur Woman of The Year 2011" and The Sikh Centennial Foundation Award 2014.When Manjit Minhas was 19 years old, she and her brother Ravinder scraped together $10,000 to launch their first beer in Alberta. In 2006, they purchased the second oldest brewery in the United States and renamed it "Minhas Craft Brewery." At the time, this acquisition officially made the Minhas siblings the youngest brewery owners in the world.Their brewery in Monroe, Wisconsin is now the 10th largest in North America, and as a brand they produce more than 90 beers, spirits, liqueurs and wines that ship all across Canada and the U.S., as well as overseas to 15 different countries. Minhas Brewery makes all of the Kirkland brand beer for Costco worldwide, as well as all the craft beers under Trader Joes' label in the US. Today they run a group of companies that generated over $155-million in revenue last year.Manjit lives in Calgary, where she was born and raised, with her husband and two young daughters.
Show more
Investment focus
- Solar, Energy, Health Care
- Angel
- Canada
Portfolio highlights
- NEXXBAR — We manufacture All-in-one, one-size-fits-all patented self-treatment tools designed to replace current tools for daily myofascial release, pain management, and recovery. The distinct benefit over other foam rollers, balls, and massage wands is the leverage system, which allows for frequent self-treatment without getting on the floor, contortinginto awkward positions, and exerting the very muscles you are trying to treat. It is portable, convenient, adaptable, and easy to use for all ages and abilities.
- Easy Platter — Easy Platter Personal chefs prepare healthy, delicious custom cuisines in your kitchen for $7.75/Meal. Top-Rated Local Personal chefs prepare incredible meals per your dietary preferences. Sit back, relax while your affordable personal chefs prepare meals for you and your family in your kitchen or
- PilotsFriend West — Precision crafted by bio-scientists and nutritionists, originally made for active duty jet pilots, PilotsFriend is a vitalizing energy tonic that promotes optimal concentration, performance, and health.
Haig Farris is one of Canada's best-known venture capitalists and experts in high-technology start-ups and turn-arounds, with a varied 30+ year history of involvement, commitment, and management. He has a law degree from the University of Pennsylvania. He is co-founder and former Executive Chair of the Board of Directors of D-Wave, and he isthe President of Fractal Capital, a private venture capital company financing high technology start-ups and resource service technology companies.Previously, Dr. Farris was a co-founder and partner of the Ventures West Management group of venture capital funds (1972-1990). In 2001, he received the British Columbia Technologies Industry Association's (BCTIA) Bill Thompson Award.He was awarded an Honorary Doctor of Laws degree from UBC in 1997 and named A Pioneer of Innovation by the Vancouver Board of Trade in 2001.
Show more
Investment focus
- Biotechnology, Genetics, Life Science
- Seed, Pre-Seed
- Canada, United States
Portfolio highlights
- Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
- Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.
Carlo Perez - CEO @ uknowa
Show more
Investment focus
- Medical, Software, Health Care
- Seed
- Canada
Portfolio highlights
- Swift Medical — Swift Medical is a digital wound care technology to improve the prevention, treatment, and management of wounds. From Capture to Claim: The world's most advanced and comprehensive wound care management software for the healthcare enterprise. Precise, consistent measurement, instant documentation and wound progression images with a smartphone.
Jacky is dedicated to angel investment and has built up a portfolio of more than thirty startup companies in Canada and the US. His target investments are the early-stage B2B companies with disruptive technologies and business potential in enterprise software, information technologies, MedTech, and Advanced Manufacturing.Jacky has acquiredconcrete business experiences as a successful founder in the startup ecosystem and an executive of Fortune 500 companies over two decades. His remarkable accomplishments range from building startups from scratch to leading a billion-dollar business with the leverage of 14,000 enterprise channel partners. The unique journey has shaped Jacky's outstanding of investing in early startups.Jacky holds the degrees of Mater's E.E. and MBA, and he graduated from CEIBS and The Wharton Business School of the University of Pennsylvania.
Show more
Investment focus
- Software, Health Care, Information Technology
- Seed, Pre-Seed, Funding Round
- Canada, United States, China
Portfolio highlights
- Workwolf — Workwolf is a Toronto-based start-up with a management team who has led 7 start-ups, had 2 successful exits, and has taken a company public with a $1.8B IPO. Workwolf CEO Erik Simins is an SME in HR who previously founded MAGNUS HRS, a staffing company now servicing over 150 enterprise customers. The technology at Workwolf solves two of the biggestpain points in employment: applicant filtration and verification, and does so by empowering users to identify better candidates faster. Winner of global awards in both 2020 and 2021 for innovation and market potential, Workwolf is ramping up for its multi-national roll-out with ManpowerGroup in September that will coincide with a $4.5M Seed financing round.
- Agile Devices — Agile Devices offer catheter-based interventional procedures helping patients during a stroke. It helps medical practitioners reduce the procedure time to respond to time bound emergencies.
- Traction Technology Partners — Traction is a powerful SaaS collaboration platform for evaluating, adopting and managing new technologies across the enterprise. The platform includes Project Management and CRM tools designed specifically for enterprise teams tasked with discovering and evaluating new technologies. Traction is used by IT, Innovation and Corp Dev teams toaccelerate their digital transformation projects, and to speed up the way they find, manage, and adopt new technologies. Traction also offers On-Demand Research services delivered through its platform.
Dr. Andrew Vellathottam is an individual investor.
Show more
Investment focus
- Robotics, Health Care, Social Impact
- Seed
- Canada
Portfolio highlights
- Able Innovations — Able Innovations is developing advanced medical devices to tackle the pressing problem of patient transfer in healthcare.
Huda is the Founder and CEO of Dot Health, a real-time personal health data platform. With a background in engineering from the University of Toronto and a prolific career at some of Toronto's best known startups including Wattpad, Wave, and Wealthsimple, her latest venture is transforming the way people access and control their own healthinformation for good. Huda's work has been featured in The Globe and Mail, Metro News, CNBC, and Metro Morning. She has been recognized amongst the Top 5 CEOs in Toronto Life and as a Top 25 Women of Influence in 2017.
Show more
Investment focus
- Wellness, Fertility, Consumer Goods
- Pre-Seed
- Canada
Portfolio highlights
- Lilia — Explore your fertility options & get help with next steps. We research your insurance coverage, lay out the egg freezing process, and can book you into a vetted clinic fast while offering on-demand support.
Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Pre-Seed
- United States, Canada, United Kingdom
Portfolio highlights
- Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
- Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
Hugo Larochelle is Research Scientist at Google and Assistant Professor at the Université de Sherbrooke (UdeS).
Show more
Investment focus
- Software, Health Care, Medical Device
- Pre-Seed
- Canada
Portfolio highlights
- Ubenwa Health — Ubenwa is a medtech company using AI to analyze infant cries, turning devices with microphones into life-saving tools for early health detection. Discover our cutting-edge technology today.
Dr. Fong is a Professor Emeritus at the Faculty of Medicine, University of Calgary. He was formerly the Head of the Department of Radiology at the University of Calgary and the Calgary Health Region. Dr. Fong is active in funding and nurturing start-up companies. Over the past two decades, he funded over 50 companies in diverse technology sectors,with an emphasis in medical devices. Dr. Fong is the co-founder and board member of Calgary Scientific Inc. and is also on the board of Clarius Mobile Health, Cohesic Inc. and Innovere Medical. In addition to seed investing, Dr. Fong is active in the Calgary community sitting on six charitable boards and foundations.In 2015, Dr. Fong joined the Creative Destruction Lab (CDL) at the University of Toronto business school as a mentor. CDL helps young entrepreneurs to shape or pivot their nascent ideas. He is widely credited with launching CDL at the Haskayne School of Business at the University of Calgary, bringing together seasoned business leaders from Alberta, Canada and the US to grow budding companies. Dr. Fong is on the Strategic Advisory Board of CDL and a Fellow of CDL in Toronto, Montreal, Calgary and Vancouver. In 2017, Dr. Fong was named to the Order of Canada for his contribution to medical technology innovation and philanthropy.
Show more
Investment focus
- Software, Artificial Intelligence, Biotechnology
- Seed, Angel, Pre-Seed
- Canada, Singapore, United States
Portfolio highlights
- Oncoustics AI — Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.
- SunGreenH2 — SunGreenH2 creates the world's highest performance advanced materials for electrolysis i.e. green hydrogen production. Achieve high efficiency, low cost green H2 production on site for your application in the Power-to-X, Hydrogen refuelling, Energy Storage and Buildings sectors. Revolutionising zero emissions and improving profitability.
- EZee Assist — EZee Assist provides instant answers to franchisee operational questions. Continue using preferred channels of support and start receiving instant answers.
Edwin Liang - CTO @ uknowa
Show more
Investment focus
- Medical, Software, Health Care
- Seed
- Canada
Portfolio highlights
- Swift Medical — Swift Medical is a digital wound care technology to improve the prevention, treatment, and management of wounds. From Capture to Claim: The world's most advanced and comprehensive wound care management software for the healthcare enterprise. Precise, consistent measurement, instant documentation and wound progression images with a smartphone.
Justin Allport
Show more
Investment focus
- Medical, Software, Health Care
- Seed
- Canada
Portfolio highlights
- Swift Medical — Swift Medical is a digital wound care technology to improve the prevention, treatment, and management of wounds. From Capture to Claim: The world's most advanced and comprehensive wound care management software for the healthcare enterprise. Precise, consistent measurement, instant documentation and wound progression images with a smartphone.
Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.
Show more
Investment focus
- Software, Artificial Intelligence, Health Care
- Seed, Series A, Angel
- United States, China, Canada
Portfolio highlights
- Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
- Playbook — Playbook gives creators the opportunity to build and grow a subscription business. Fans get an all-access pass to a curated health and wellness content.
- Crossing — Crossing Media is a live broadcast e-commerce service company that builds awareness, engagement, and sales through live-stream shopping.
Dr. Gaurav Puri graduated from Himachal Dental College in 2002. Following the same career path as Dr. Dhir, they have worked together their entire careers. As the Chief Dental Officer, Dr. Puri spends the vast majority of this time working in the practices. He routinely works with associate providers to increase their skills and ability. He alsotakes on the most challenging cases.
Show more
Investment focus
- Robotics, Health Care, Social Impact
- Seed
- Canada
Portfolio highlights
- Able Innovations — Able Innovations is developing advanced medical devices to tackle the pressing problem of patient transfer in healthcare.
Investors by industry
Biotech
Proptech
Gaming
FinTech
Health Care
Community
Google
Marketplace
Climate
Consumer
Artificial intelligence
Impact
Energy
Hardware
EdTech
Sustainability
Venture Capital
Clean Energy
B2B
Real Estate
Publishing
Payments
Big Data
Retail
Organic Food
Web3
Education
Finance
Food and Beverage
Video Games
Infrastructure
Financial Services
Photography
Beauty
Medical
Wellness
Social Media
Social Network
Android
Construction
Art
Local
Legal
Digital Media
Manufacturing
eSports
Sports
Music
Mobile
Internet
Enterprise Software
Franchise
Email
Travel
Mobile Advertising
Biotechnology
Recruiting
Hospitality
Fitness
Platforms
Cannabis
Medical Device
Social
Automotive
Crowdfunding
Wine And Spirits
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Film
Theatre
Non Profit
Renewable Energy
SaaS
Sporting Goods
Social Impact
Restaurants
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Canada
New Zealand
Ireland
United States
Qatar
Saudi Arabia
Spain
Sri Lanka
China
Middle East
Africa
Indonesia
Europe
Armenia
Singapore
Oceania
Brazil
Japan
South Africa
Vietnam
LATAM
Asia
Denmark
Costa Rica
Bermuda
Egypt
Croatia
Gibraltar
Algeria
Estonia
Ecuador
Greece
Chile
Bulgaria
Ethiopia
Hong Kong
Faroe Islands
France
Ghana
Czech Republic
Hungary
Georgia
Belgium
Finland
Bahrain
Belarus
Lebanon
Belize
Mali
Liberia
Malta
Liechtenstein
Malaysia
Italy
Panama
Myanmar
Mauritius
Nicaragua
Philippines
Lithuania
Israel
Jersey
Norway
Morocco
Mexico
Peru
Kuwait
Puerto Rico
Tunisia
Barbados
Uganda
Dominican Republic
Sierra Leone
Senegal
San Marino
Uzbekistan
Seychelles
Togo
El Salvador
Azerbaijan
Rwanda
Russian Federation
Tanzania
Ukraine
Zimbabwe
Uruguay
Serbia
Taiwan
Venezuela
Tajikistan
Sweden
Turkey
Poland
Thailand
Zambia
Portugal
Slovenia
United Arab Emirates
Jamaica
Iraq
Iceland
Honduras
Bolivia
Isle of Man
Bahamas
Luxembourg
Namibia
Nigeria
Albania
Pakistan
Bangladesh
Argentina
Grenada
Jordan
Romania
Kenya
Kazakhstan
Cayman Islands
Cambodia
Cyprus
Latvia
Oman
Cameroon
Austria
Switzerland
Guatemala
Colombia
Marshall Islands
Angel Investors in Canada by industry
Transportation
FinTech
Consumer
EdTech
Impact
SaaS
Community
Artificial intelligence
Hardware
Gaming
Health Care
Energy
Big Data
Restaurants
Venture Capital
Real Estate
Infrastructure
Fashion
Mobile Apps
Beauty
Web3
Retail
Education
Financial Services
Cryptocurrency
Finance
Payments
Organic Food
Medical
Video Games
Medical Device
Wellness
Sustainability
Email
Internet
Photography
Social Media
Music
Manufacturing
Art
Digital Media
Mobile
Social Network
Enterprise
Legal
Construction
Local
Software
eSports
Enterprise Software
Fitness
CleanTech
Travel
Hospitality
Automotive
InsurTech
Recruiting
Biotechnology
Cannabis
B2B
Publishing
Oil and Gas
Renewable Energy
Blockchain
Wine And Spirits
Life Science
Biotech
Sports
Proptech
Marketplace
Climate
Food and Beverage
Media (entertainment)
Platforms
Agriculture (agtech)